APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mycology Immunoassays Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Mycology Immunoassays Testing Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchMycology Immunoassays Testing Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Mycology Immunoassays Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Mycology Immunoassays Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mycology Immunoassays Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mycology Immunoassays Testing Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Mycology Immunoassays Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Mycology Immunoassays Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Mycology Immunoassays Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Mycology Immunoassays Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Mycology Immunoassays Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Mycology Immunoassays Testing include Abbott, Roche, CapitalBio Corporation, Autobio Diagnostics CO.,Ltd., Siemens, Ortho-Clinical Diagnostics, MiraVista Diagnostics, ELITechGroup and bioMérieux, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Mycology Immunoassays Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Mycology Immunoassays Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Mycology Immunoassays Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Mycology Immunoassays Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Mycology Immunoassays Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Mycology Immunoassays Testing revenue, projected growth trends, production technology, application and end-user industry.

Mycology Immunoassays Testing Segment by Company

Abbott

Roche

CapitalBio Corporation

Autobio Diagnostics CO.,Ltd.

Siemens

Ortho-Clinical Diagnostics

MiraVista Diagnostics

ELITechGroup

bioMérieux

Beckman Coulter

Mycology Immunoassays Testing Segment by Type

ELISA

ELISPOT

Polymerase Chain Reaction (PCR)

Rapid Tests

Mycology Immunoassays Testing Segment by Application

Hospitals

Blood Banks

Others

Mycology Immunoassays Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycology Immunoassays Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mycology Immunoassays Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycology Immunoassays Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Mycology Immunoassays Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Mycology Immunoassays Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mycology Immunoassays Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Mycology Immunoassays Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ELISA Major Player Table 3. ELISPOT Major Player Table 4. Polymerase Chain Reaction (PCR) Major Player Table 5. Rapid Tests Major Player Table 6. Global Mycology Immunoassays Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospitals Major Player Table 8. Blood Banks Major Player Table 9. Others Major Player Table 10. Mycology Immunoassays Testing Industry Trends Table 11. Mycology Immunoassays Testing Industry Drivers Table 12. Mycology Immunoassays Testing Industry Opportunities and Challenges Table 13. Mycology Immunoassays Testing Industry Restraints Table 14. Global Mycology Immunoassays Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Mycology Immunoassays Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Mycology Immunoassays Testing Market Share by Region (2021-2026) Table 17. Global Mycology Immunoassays Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Mycology Immunoassays Testing Market Share by Region (2027-2032) Table 19. Global Mycology Immunoassays Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Mycology Immunoassays Testing Revenue Market Share by Players (2021-2026) Table 21. Global Mycology Immunoassays Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Mycology Immunoassays Testing Key Players Headquarters & Area Served Table 23. Global Mycology Immunoassays Testing Players, Product Type & Application Table 24. Global Mycology Immunoassays Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Mycology Immunoassays Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Mycology Immunoassays Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Mycology Immunoassays Testing Revenue Market Share by Type (2021-2026) Table 31. Global Mycology Immunoassays Testing Revenue Market Share by Type (2027-2032) Table 32. Global Mycology Immunoassays Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Mycology Immunoassays Testing Revenue Market Share by Application (2021-2026) Table 36. Global Mycology Immunoassays Testing Revenue Market Share by Application (2027-2032) Table 37. Abbott Company Information Table 38. Abbott Business Overview Table 39. Abbott Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Abbott Mycology Immunoassays Testing Product Portfolio Table 41. Abbott Recent Development Table 42. Roche Company Information Table 43. Roche Business Overview Table 44. Roche Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Roche Mycology Immunoassays Testing Product Portfolio Table 46. Roche Recent Development Table 47. CapitalBio Corporation Company Information Table 48. CapitalBio Corporation Business Overview Table 49. CapitalBio Corporation Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio Table 51. CapitalBio Corporation Recent Development Table 52. Autobio Diagnostics CO.,Ltd. Company Information Table 53. Autobio Diagnostics CO.,Ltd. Business Overview Table 54. Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio Table 56. Autobio Diagnostics CO.,Ltd. Recent Development Table 57. Siemens Company Information Table 58. Siemens Business Overview Table 59. Siemens Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Siemens Mycology Immunoassays Testing Product Portfolio Table 61. Siemens Recent Development Table 62. Ortho-Clinical Diagnostics Company Information Table 63. Ortho-Clinical Diagnostics Business Overview Table 64. Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio Table 66. Ortho-Clinical Diagnostics Recent Development Table 67. MiraVista Diagnostics Company Information Table 68. MiraVista Diagnostics Business Overview Table 69. MiraVista Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio Table 71. MiraVista Diagnostics Recent Development Table 72. ELITechGroup Company Information Table 73. ELITechGroup Business Overview Table 74. ELITechGroup Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. ELITechGroup Mycology Immunoassays Testing Product Portfolio Table 76. ELITechGroup Recent Development Table 77. bioMérieux Company Information Table 78. bioMérieux Business Overview Table 79. bioMérieux Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. bioMérieux Mycology Immunoassays Testing Product Portfolio Table 81. bioMérieux Recent Development Table 82. Beckman Coulter Company Information Table 83. Beckman Coulter Business Overview Table 84. Beckman Coulter Mycology Immunoassays Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Beckman Coulter Mycology Immunoassays Testing Product Portfolio Table 86. Beckman Coulter Recent Development Table 87. North America Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Mycology Immunoassays Testing Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Mycology Immunoassays Testing Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Mycology Immunoassays Testing Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Mycology Immunoassays Testing Revenue by Country (US$ Million) & (2027-2032) Table 101. China Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 102. China Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 103. China Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 104. China Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Mycology Immunoassays Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Mycology Immunoassays Testing Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Mycology Immunoassays Testing Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Mycology Immunoassays Testing Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Mycology Immunoassays Testing Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Mycology Immunoassays Testing Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Mycology Immunoassays Testing Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Mycology Immunoassays Testing Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Mycology Immunoassays Testing Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Mycology Immunoassays Testing Image Figure 2. Global Mycology Immunoassays Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mycology Immunoassays Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. ELISA Image Figure 5. ELISPOT Image Figure 6. Polymerase Chain Reaction (PCR) Image Figure 7. Rapid Tests Image Figure 8. Global Mycology Immunoassays Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Mycology Immunoassays Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospitals Image Figure 11. Blood Banks Image Figure 12. Others Image Figure 13. Global Mycology Immunoassays Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Mycology Immunoassays Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Mycology Immunoassays Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Mycology Immunoassays Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Mycology Immunoassays Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Mycology Immunoassays Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Mycology Immunoassays Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Mycology Immunoassays Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Mycology Immunoassays Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Mycology Immunoassays Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Mycology Immunoassays Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Mycology Immunoassays Testing Revenue Share by Type (2021-2032) Figure 26. North America Mycology Immunoassays Testing Revenue Share by Application (2021-2032) Figure 27. North America Mycology Immunoassays Testing Revenue Share by Country (2021-2032) Figure 28. United States Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Mycology Immunoassays Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Mycology Immunoassays Testing Revenue Share by Type (2021-2032) Figure 33. Europe Mycology Immunoassays Testing Revenue Share by Application (2021-2032) Figure 34. Europe Mycology Immunoassays Testing Revenue Share by Country (2021-2032) Figure 35. Germany Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Mycology Immunoassays Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Mycology Immunoassays Testing Revenue Share by Type (2021-2032) Figure 45. China Mycology Immunoassays Testing Revenue Share by Application (2021-2032) Figure 46. Asia Mycology Immunoassays Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Mycology Immunoassays Testing Revenue Share by Type (2021-2032) Figure 48. Asia Mycology Immunoassays Testing Revenue Share by Application (2021-2032) Figure 49. Asia Mycology Immunoassays Testing Revenue Share by Region (2021-2032) Figure 50. Japan Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Mycology Immunoassays Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Mycology Immunoassays Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Mycology Immunoassays Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Mycology Immunoassays Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Mycology Immunoassays Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • ELISPOT
  • Polymerase Chain Reaction (PCR)
  • Rapid Tests
Applications
  • Hospitals
  • Blood Banks
  • Others
Companies covered
  • Abbott
  • Roche
  • CapitalBio Corporation
  • Autobio Diagnostics CO.,Ltd.
  • Siemens
  • Ortho-Clinical Diagnostics
  • MiraVista Diagnostics
  • ELITechGroup
  • bioMérieux
  • Beckman Coulter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Mycology Immunoassays Testing Market by Type
  3. 1.2.1 Global Mycology Immunoassays Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA
  5. 1.2.3 ELISPOT
  6. 1.2.4 Polymerase Chain Reaction (PCR)
  7. 1.2.5 Rapid Tests
  8. 1.3 Mycology Immunoassays Testing Market by Application
  9. 1.3.1 Global Mycology Immunoassays Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals
  11. 1.3.3 Blood Banks
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Mycology Immunoassays Testing Market Dynamics
  1. 2.1 Mycology Immunoassays Testing Industry Trends
  2. 2.2 Mycology Immunoassays Testing Industry Drivers
  3. 2.3 Mycology Immunoassays Testing Industry Opportunities and Challenges
  4. 2.4 Mycology Immunoassays Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Mycology Immunoassays Testing Market Perspective (2021-2032)
  2. 3.2 Global Mycology Immunoassays Testing Growth Trends by Region
  3. 3.2.1 Global Mycology Immunoassays Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Mycology Immunoassays Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Mycology Immunoassays Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Mycology Immunoassays Testing Revenue by Players
  2. 4.1.1 Global Mycology Immunoassays Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Mycology Immunoassays Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Mycology Immunoassays Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Mycology Immunoassays Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Mycology Immunoassays Testing Key Players Headquarters & Area Served
  7. 4.4 Global Mycology Immunoassays Testing Players, Product Type & Application
  8. 4.5 Global Mycology Immunoassays Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Mycology Immunoassays Testing Market CR5 and HHI
  11. 4.6.3 2025 Mycology Immunoassays Testing Tier 1, Tier 2, and Tier 3
5 Mycology Immunoassays Testing Market Size by Type
  1. 5.1 Global Mycology Immunoassays Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 5.3 Global Mycology Immunoassays Testing Revenue Market Share by Type (2021-2032)
6 Mycology Immunoassays Testing Market Size by Application
  1. 6.1 Global Mycology Immunoassays Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Mycology Immunoassays Testing Revenue by Application (2021-2032)
  3. 6.3 Global Mycology Immunoassays Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Mycology Immunoassays Testing Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Roche Mycology Immunoassays Testing Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 CapitalBio Corporation
  14. 7.3.1 CapitalBio Corporation Company Information
  15. 7.3.2 CapitalBio Corporation Business Overview
  16. 7.3.3 CapitalBio Corporation Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CapitalBio Corporation Mycology Immunoassays Testing Product Portfolio
  18. 7.3.5 CapitalBio Corporation Recent Developments
  19. 7.4 Autobio Diagnostics CO.,Ltd.
  20. 7.4.1 Autobio Diagnostics CO.,Ltd. Company Information
  21. 7.4.2 Autobio Diagnostics CO.,Ltd. Business Overview
  22. 7.4.3 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Autobio Diagnostics CO.,Ltd. Mycology Immunoassays Testing Product Portfolio
  24. 7.4.5 Autobio Diagnostics CO.,Ltd. Recent Developments
  25. 7.5 Siemens
  26. 7.5.1 Siemens Company Information
  27. 7.5.2 Siemens Business Overview
  28. 7.5.3 Siemens Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Siemens Mycology Immunoassays Testing Product Portfolio
  30. 7.5.5 Siemens Recent Developments
  31. 7.6 Ortho-Clinical Diagnostics
  32. 7.6.1 Ortho-Clinical Diagnostics Company Information
  33. 7.6.2 Ortho-Clinical Diagnostics Business Overview
  34. 7.6.3 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Ortho-Clinical Diagnostics Mycology Immunoassays Testing Product Portfolio
  36. 7.6.5 Ortho-Clinical Diagnostics Recent Developments
  37. 7.7 MiraVista Diagnostics
  38. 7.7.1 MiraVista Diagnostics Company Information
  39. 7.7.2 MiraVista Diagnostics Business Overview
  40. 7.7.3 MiraVista Diagnostics Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MiraVista Diagnostics Mycology Immunoassays Testing Product Portfolio
  42. 7.7.5 MiraVista Diagnostics Recent Developments
  43. 7.8 ELITechGroup
  44. 7.8.1 ELITechGroup Company Information
  45. 7.8.2 ELITechGroup Business Overview
  46. 7.8.3 ELITechGroup Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ELITechGroup Mycology Immunoassays Testing Product Portfolio
  48. 7.8.5 ELITechGroup Recent Developments
  49. 7.9 bioMérieux
  50. 7.9.1 bioMérieux Company Information
  51. 7.9.2 bioMérieux Business Overview
  52. 7.9.3 bioMérieux Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 bioMérieux Mycology Immunoassays Testing Product Portfolio
  54. 7.9.5 bioMérieux Recent Developments
  55. 7.10 Beckman Coulter
  56. 7.10.1 Beckman Coulter Company Information
  57. 7.10.2 Beckman Coulter Business Overview
  58. 7.10.3 Beckman Coulter Mycology Immunoassays Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Beckman Coulter Mycology Immunoassays Testing Product Portfolio
  60. 7.10.5 Beckman Coulter Recent Developments
8 North America
  1. 8.1 North America Mycology Immunoassays Testing Revenue (2021-2032)
  2. 8.2 North America Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Mycology Immunoassays Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Mycology Immunoassays Testing Revenue by Type (2027-2032)
  5. 8.3 North America Mycology Immunoassays Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Mycology Immunoassays Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Mycology Immunoassays Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Mycology Immunoassays Testing Revenue by Application (2027-2032)
  9. 8.5 North America Mycology Immunoassays Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Mycology Immunoassays Testing Revenue by Country
  11. 8.6.1 North America Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Mycology Immunoassays Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Mycology Immunoassays Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Mycology Immunoassays Testing Revenue (2021-2032)
  2. 9.2 Europe Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Mycology Immunoassays Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Mycology Immunoassays Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Mycology Immunoassays Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Mycology Immunoassays Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Mycology Immunoassays Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Mycology Immunoassays Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Mycology Immunoassays Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Mycology Immunoassays Testing Revenue by Country
  11. 9.6.1 Europe Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Mycology Immunoassays Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Mycology Immunoassays Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Mycology Immunoassays Testing Revenue (2021-2032)
  2. 10.2 China Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Mycology Immunoassays Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Mycology Immunoassays Testing Revenue by Type (2027-2032)
  5. 10.3 China Mycology Immunoassays Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Mycology Immunoassays Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Mycology Immunoassays Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Mycology Immunoassays Testing Revenue by Application (2027-2032)
  9. 10.5 China Mycology Immunoassays Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Mycology Immunoassays Testing Revenue (2021-2032)
  2. 11.2 Asia Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Mycology Immunoassays Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Mycology Immunoassays Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Mycology Immunoassays Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Mycology Immunoassays Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Mycology Immunoassays Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Mycology Immunoassays Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Mycology Immunoassays Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Mycology Immunoassays Testing Revenue by Country
  11. 11.6.1 Asia Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Mycology Immunoassays Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Mycology Immunoassays Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Mycology Immunoassays Testing Revenue (2021-2032)
  2. 12.2 SAMEA Mycology Immunoassays Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Mycology Immunoassays Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Mycology Immunoassays Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Mycology Immunoassays Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Mycology Immunoassays Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Mycology Immunoassays Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Mycology Immunoassays Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Mycology Immunoassays Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Mycology Immunoassays Testing Revenue by Country
  11. 12.6.1 SAMEA Mycology Immunoassays Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Mycology Immunoassays Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Mycology Immunoassays Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst